Search - tctmd.com

Displaying 421 - 440 of 441

Sort: Relevancy | Date

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

September 26, 2011

News Conference News

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

September 01, 2011

News Industry News

First Patient Enrolls in St. Jude Medical Supported Landmark Study Investigating Atrial Fibrillation Treatment Options

August 02, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

July 18, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

June 24, 2011

News Daily News

Study Examines Predictors of Thrombus Aspiration Failure in Primary PCI

June 22, 2011

News Daily News

EES Show Long-term Safety Advantage over SES

May 24, 2011

News Daily News

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

April 21, 2011

News Conference News

Radial vs. Femoral Angioplasty: Still RIVALs

April 04, 2011

News Conference News

PARTNER: TAVI Cost Effective Compared With Standard Care

April 03, 2011

News Daily News

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

February 06, 2011

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

CME

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

PLX Pharma - Aspirin for the Interventionalist: More Than Meets the Eye

CME

Aspirin for the Interventionalist: More Than Meets the Eye

Everyday Antiplatelet Decisions: Making the Right Choices

CME

Everyday Antiplatelet Decisions: Making the Right Choices

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

CME

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

News Industry News

Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

CME

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.